NCT03410394

Brief Summary

This registry aims to collect informations about patients with endocrine tumors (Thyroid, Parathyroid, Adrenal, Endocrine Pancreas, Endocrine Digestive Tube) who undergo endocrine surgical procedures. This registry is part of the Eurocrine Project.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,000

participants targeted

Target at P75+ for all trials

Timeline
45mo left

Started Jan 2015

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress76%
Jan 2015Jan 2030

Study Start

First participant enrolled

January 1, 2015

Completed
3 years until next milestone

First Submitted

Initial submission to the registry

January 10, 2018

Completed
15 days until next milestone

First Posted

Study publicly available on registry

January 25, 2018

Completed
11.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2030

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2030

Last Updated

February 12, 2025

Status Verified

February 1, 2025

Enrollment Period

15 years

First QC Date

January 10, 2018

Last Update Submit

February 11, 2025

Conditions

Keywords

adrenalthyroidparathyroidendocrine pancreasendocrine digestive tube

Outcome Measures

Primary Outcomes (1)

  • Postoperative complications (endocrine surgical procedure)

    morbidity rate in percentage (%)

    12 months after surgical procedure

Secondary Outcomes (13)

  • Postoperative complications severity (endocrine surgical procedure)

    12 months after surgical procedure

  • Postoperative mortality (endocrine surgical procedure)

    12 months after surgical procedure

  • CT imaging before endocrine surgical procedure (Tumor characteristics)

    Baseline

  • CT imaging before endocrine surgical procedure (Coronary artery score)

    Baseline

  • CT imaging before endocrine surgical procedure (Sarcopenia)

    preoperative period

  • +8 more secondary outcomes

Study Arms (1)

registry of endocrine tumors

* Patients who undergo thyroid surgical procedures. This registry was declared at the commission national informatique et libertés (CNIL) with the number R2015-22. * Patients who undergo parathyroid surgical procedures. This registry was declared at the commission national informatique et libertés (CNIL) with the number R2015-23 * Patients who undergo adrenal surgical procedures. This registry was declared at the commission national informatique et libertés (CNIL) with the number R2015-24 * Patients who undergo pancreatic and digestive surgical procedures. This registry was declared at the commission national informatique et libertés (CNIL) with the number R2015-26

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients who undergo surgical procedures for endocrine tumors at CHU Nancy Brabois (University hospital)

You may qualify if:

  • patients who undergo surgical procedures for endocrine tumors at the University Nancy Brabois Hospital

You may not qualify if:

  • unable to receive clear information
  • refusal to sign the consent form

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Nancy

Vandœuvre-lès-Nancy, 54511, France

RECRUITING

Related Publications (1)

  • Greilsamer T, Nomine-Criqui C, Thy M, Ullmann T, Zarnegar R, Bresler L, Brunaud L. Robotic-assisted unilateral adrenalectomy: risk factors for perioperative complications in 303 consecutive patients. Surg Endosc. 2019 Mar;33(3):802-810. doi: 10.1007/s00464-018-6346-2. Epub 2018 Jul 11.

Related Links

Biospecimen

Retention: SAMPLES WITH DNA

samples from tumor specimen. All patients signed a specific and validated form allowing the collection of samples with DNA (CNIL N° DC2014-2114)

MeSH Terms

Conditions

Endocrine Gland NeoplasmsThyroid Diseases

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsEndocrine System Diseases

Study Officials

  • laurent Brunaud

    University of Lorraine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

laurent Brunaud, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
10 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
investigator

Study Record Dates

First Submitted

January 10, 2018

First Posted

January 25, 2018

Study Start

January 1, 2015

Primary Completion (Estimated)

January 1, 2030

Study Completion (Estimated)

January 1, 2030

Last Updated

February 12, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations